Created at	Source	Raw Value	Validated value
Dec. 9, 2020, 12:31 a.m.	usa	CD4+/CD8+ proliferating cells;SARS-CoV-2 glycoprotein-specific antibodies titer;Seroconversion rate;IFN-gamma antigen-specific release;Virus-neutralizing antibodies titer	CD4+/CD8+ proliferating cells;SARS-CoV-2 glycoprotein-specific antibodies titer;Seroconversion rate;IFN-gamma antigen-specific release;Virus-neutralizing antibodies titer